Jazz Pharmaceuticals’ epilepsy drug advances into phase 3 trial

22nd August 2022 Uncategorised 0

Epidiolex may ease symptoms associated with Doose syndrome, a rarer type of childhood-onset epilepsy

More: Jazz Pharmaceuticals’ epilepsy drug advances into phase 3 trial
Source: News